.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Find suppliers and generic API sources
  • Predict branded drug patent expiration

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
McKinsey
Cerilliant
Fuji
US Department of Justice
Harvard Business School
Cipla
Express Scripts
Merck
Boehringer Ingelheim

Generated: June 24, 2017

DrugPatentWatch Database Preview

OLOPATADINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Olopatadine Hydrochloride, and what generic Olopatadine Hydrochloride alternatives are available?

Olopatadine Hydrochloride is a drug marketed by Somerset Theraps Llc, Zach System Spa, Aurobindo Pharma Ltd, Akorn Inc, Barr Labs Inc, Apotex Inc, Usv North America, and Perrigo Israel. and is included in nine NDAs.

The generic ingredient in OLOPATADINE HYDROCHLORIDE is olopatadine hydrochloride. There are sixteen drug master file entries for this compound. Fifteen suppliers are listed for this compound. There are five tentative approvals for this compound. Additional details are available on the olopatadine hydrochloride profile page.

Summary for Tradename: OLOPATADINE HYDROCHLORIDE

Patents:0
Applicants:8
NDAs:9
Suppliers / Packagers: see list9
Bulk Api Vendors: see list73
Clinical Trials: see list2,262
Patent Applications: see list1,715
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:OLOPATADINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: OLOPATADINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Somerset Theraps Llc
OLOPATADINE HYDROCHLORIDE
olopatadine hydrochloride
SOLUTION/DROPS;OPHTHALMIC206306-001Dec 7, 2015ATRXNoNo► Subscribe► Subscribe
Usv North America
OLOPATADINE HYDROCHLORIDE
olopatadine hydrochloride
SOLUTION/DROPS;OPHTHALMIC203152-001Dec 7, 2015ATRXNoNo► Subscribe► Subscribe
Akorn Inc
OLOPATADINE HYDROCHLORIDE
olopatadine hydrochloride
SOLUTION/DROPS;OPHTHALMIC204532-001Jan 10, 2017ATRXNoNo► Subscribe► Subscribe
Perrigo Israel
OLOPATADINE HYDROCHLORIDE
olopatadine hydrochloride
SPRAY, METERED;NASAL202853-001Jan 31, 2017ABRXNoNo► Subscribe► Subscribe
Zach System Spa
OLOPATADINE HYDROCHLORIDE
olopatadine hydrochloride
SOLUTION/DROPS;OPHTHALMIC204706-001Dec 7, 2015ATRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Argus Health
Fish and Richardson
Federal Trade Commission
Merck
Colorcon
UBS
Cerilliant
Chubb
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot